SUPERNUS PHARMACEUTICALS, INC. - 8-K Filing

Supernus Pharmaceuticals and Indivior announce conference call on August 3, 2026 regarding their proposed merger. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $SUPN

Read the full article at SEC EDGAR

More Regulatory news